These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 23629540)

  • 21. Characterization of Micro-RNA Changes during the Progression of Type 2 Diabetes in Zucker Diabetic Fatty Rats.
    Delic D; Eisele C; Schmid R; Luippold G; Mayoux E; Grempler R
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27153060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal dynamics of serum let-7g expression mirror the decline of residual beta-cell function in longitudinal observation of children with type 1 diabetes.
    Małachowska B; Wyka K; Nowicka Z; Bartłomiejczyk MA; Młynarski W; Fendler W
    Pediatr Diabetes; 2018 Dec; 19(8):1407-1415. PubMed ID: 30259606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.
    Jimenez-Lucena R; Alcala-Diaz JF; Roncero-Ramos I; Lopez-Moreno J; Camargo A; Gomez-Delgado F; Quintana-Navarro GM; Vals-Delgado C; Rodriguez-Cantalejo F; Luque RM; Delgado-Lista J; Ordovas JM; Perez-Martinez P; Rangel-Zuñiga OA; Lopez-Miranda J
    Clin Nutr; 2021 Mar; 40(3):1028-1038. PubMed ID: 32723508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of microRNAs in diabetes mellitus.
    Chen H; Lan HY; Roukos DH; Cho WC
    J Endocrinol; 2014 Jul; 222(1):R1-R10. PubMed ID: 24781254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus.
    Takahashi P; Xavier DJ; Evangelista AF; Manoel-Caetano FS; Macedo C; Collares CV; Foss-Freitas MC; Foss MC; Rassi DM; Donadi EA; Passos GA; Sakamoto-Hojo ET
    Gene; 2014 Apr; 539(2):213-23. PubMed ID: 24530307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D.
    La Sala L; Mrakic-Sposta S; Tagliabue E; Prattichizzo F; Micheloni S; Sangalli E; Specchia C; Uccellatore AC; Lupini S; Spinetti G; de Candia P; Ceriello A
    Cardiovasc Diabetol; 2019 Feb; 18(1):18. PubMed ID: 30803440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating microRNA as a diagnostic marker in populations with type 2 diabetes mellitus and diabetic complications.
    Chien HY; Lee TP; Chen CY; Chiu YH; Lin YC; Lee LS; Li WC
    J Chin Med Assoc; 2015 Apr; 78(4):204-11. PubMed ID: 25529478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus.
    Wang C; Wan S; Yang T; Niu D; Zhang A; Yang C; Cai J; Wu J; Song J; Zhang CY; Zhang C; Wang J
    Sci Rep; 2016 Feb; 6():20032. PubMed ID: 26831044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.
    Åkerman L; Casas R; Ludvigsson J; Tavira B; Skoglund C
    PLoS One; 2018; 13(1):e0191067. PubMed ID: 29346396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine-tuning of microRNAs in Type 2 Diabetes Mellitus.
    Rosado JA; Diez-Bello R; Salido GM; Jardin I
    Curr Med Chem; 2019; 26(22):4102-4118. PubMed ID: 29210640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review.
    Pordzik J; Jakubik D; Jarosz-Popek J; Wicik Z; Eyileten C; De Rosa S; Indolfi C; Siller-Matula JM; Czajka P; Postula M
    Cardiovasc Diabetol; 2019 Aug; 18(1):113. PubMed ID: 31470851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.
    Pan S; Li M; Yu H; Xie Z; Li X; Duan X; Huang G; Zhou Z
    Acta Diabetol; 2021 Jan; 58(1):63-72. PubMed ID: 32815005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes.
    Santos AS; Cunha Neto E; Fukui RT; Ferreira LRP; Silva MER
    Front Immunol; 2019; 10():1637. PubMed ID: 31396209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress.
    Kamalden TA; Macgregor-Das AM; Kannan SM; Dunkerly-Eyring B; Khaliddin N; Xu Z; Fusco AP; Yazib SA; Chow RC; Duh EJ; Halushka MK; Steenbergen C; Das S
    Antioxid Redox Signal; 2017 Nov; 27(13):913-930. PubMed ID: 28173719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
    Cui X; You L; Zhu L; Wang X; Zhou Y; Li Y; Wen J; Xia Y; Wang X; Ji C; Guo X
    Metabolism; 2018 Jan; 78():95-105. PubMed ID: 28966078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
    Nunez Lopez YO; Garufi G; Seyhan AA
    Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micromanaging Glucose Tolerance and Diabetes.
    Saliani N; Montazersaheb S; Montasser Kouhsari S
    Adv Pharm Bull; 2017 Dec; 7(4):547-556. PubMed ID: 29399544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of stress-related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta-analysis.
    Liang YZ; Li JJ; Xiao HB; He Y; Zhang L; Yan YX
    J Diabetes; 2020 Sep; 12(9):633-644. PubMed ID: 29341487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNAs and adipocytokines: Promising biomarkers for pharmacological targets in diabetes mellitus and its complications.
    Ashoori MR; Rahmati-Yamchi M; Ostadrahimi A; Fekri Aval S; Zarghami N
    Biomed Pharmacother; 2017 Sep; 93():1326-1336. PubMed ID: 28747014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
    Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
    Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.